Skip to search form
Skip to main content
Skip to account menu
Semantic Scholar
Semantic Scholar's Logo
Search 228,754,249 papers from all fields of science
Search
Sign In
Create Free Account
University of Texas MD Anderson Cancer Center
Known as:
MDACC
, University of Texas M D Anderson Cancer Center
The mission areas of the University of Texas MD Anderson Cancer Center include patient care, research, education, and prevention, with an emphasis on…
Expand
National Institutes of Health
Create Alert
Alert
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
Review
2016
Review
2016
Breast reconstruction at the MD Anderson Cancer Center.
P. Yu
Gland surgery
2016
Corpus ID: 26715953
The introduction of the transverse rectus abdominis myocutaneous flap in the 1970s marks the beginning of modern breast…
Expand
2015
2015
Low-Dose Hypomethylating Agents (HMAs) Are Effective in Patients (Pts) with Low- or Intermediate-1-Risk Myelodysplastic Syndrome (MDS): A Report on Behalf of the MDS Clinical Research Consortium
N. Short
,
G. Garcia-Manero
,
+16 authors
E. Jabbour
2015
Corpus ID: 208432564
Background: HMAs improve survival of pts with higher-risk MDS; however, the role of HMAs is less clear in pts with lower-risk MDS…
Expand
2013
2013
The utility of two prognostic models for predicting time to first treatment in early chronic lymphocytic leukemia patients: results of a comparative analysis.
S. Molica
,
D. Giannarelli
,
+7 authors
F. Morabito
Leukemia research : a Forum for Studies on…
2013
Corpus ID: 22227493
Review
2011
Review
2011
Self-Expanding Metal Stents for Biliary Drainage in Patients with Resectable Pancreatic Cancer: Single-Center Experience with 79 Cases
A. Singal
,
W. Ross
,
+8 authors
Jeffrey H. Lee
Digestive Diseases and Sciences
2011
Corpus ID: 36770821
Background and AimsTo study pre-operative and peri-operative course and outcome on follow up after pancreaticoduodenenctomy (PD…
Expand
2010
2010
Interim data for ACT III: Phase II trial of PF-04948568 (CDX-110) in combination with temozolomide (TMZ) in patients (pts) with glioblastoma (GBM).
R. Lai
,
L. Recht
,
+7 authors
J. Sampson
2010
Corpus ID: 74302009
2014 Background: EGFRvIII is a constitutively activated mutation of EGFR, not expressed in normal tissues but expressed in GBM…
Expand
2008
2008
Serum CA 19–9 level as a surrogate marker for prognosis in locally advanced pancreatic cancer (LAPC)
D. Fogelman
,
P. Pathak
,
+6 authors
M. Javle
2008
Corpus ID: 78222375
15514 Background: Assessing the efficacy of treatment for locally advanced pancreatic cancer (LAPC) via CT is inadequate…
Expand
2005
2005
Status of health insurance predicts time from symptom onset to cancer diagnosis (TDx) in young adults
A. Bleyer
,
C. Ulrich
,
Sean K. Martin
,
M. Munsell
,
G. Lange
,
Sarah H. Taylor
2005
Corpus ID: 74623474
6079 Background: Young adults and older adolescents diagnosed to have cancer have had less progress in survival improvement than…
Expand
Review
2004
Review
2004
Multidisciplinary approach to cancer treatment: a model for breast cancer treatment at the M.D. Anderson Cancer Center
R. Kim
,
T. Toge
International Journal of Clinical Oncology
2004
Corpus ID: 1462690
Despite that fact that a multidisciplinary approach is important for cancer treatment, this approach is not widely used in Japan…
Expand
Highly Cited
2000
Highly Cited
2000
Molecular response assessed by PCR is the most important factor predicting failure-free survival in indolent follicular lymphoma: update of the MDACC series.
A. López-Guillermo
,
F. Cabanillas
,
+9 authors
M. Lee
Annals of Oncology
2000
Corpus ID: 8913929
BACKGROUND We have observed that molecular response, as defined by a PCR-negative status during the first year of therapy, along…
Expand
Review
1999
Review
1999
Hodgkin's disease with lymphocyte predominance: long-term results based on current histopathologic criteria.
C. Ha
,
V. Kavadi
,
+8 authors
J. Cox
International Journal of Radiation Oncology…
1999
Corpus ID: 24166529
By clicking accept or continuing to use the site, you agree to the terms outlined in our
Privacy Policy
(opens in a new tab)
,
Terms of Service
(opens in a new tab)
, and
Dataset License
(opens in a new tab)
ACCEPT & CONTINUE
or Only Accept Required